Yven Van Herrewege

Medicine & Life Sciences

1. Rabies 100%
2. Pre-Exposure Prophylaxis 77%
3. Mouthwashes 69%
4. Belgium 69%
5. Sexual and Gender Minorities 54%
6. Equivalence Trials 44%
7. Post-Exposure Prophylaxis 38%
8. Artesunate 37%
9. Mefloquine 37%
10. Oropharynx 35%
11. Gonorrhea 34%
12. Chlorhexidine 32%
13. Neisseria gonorrhoeae 31%
14. Schistosomiasis 31%
15. Antibody Formation 27%
16. Sexually Transmitted Diseases 26%
17. Appointments and Schedules 25%
18. Cross-Over Studies 24%
19. Immunoglobulins 23%
20. Child 23%
21. Vaccination 22%
22. Rabies Vaccines 22%
23. Clinical Trials 20%
24. Praziquantel 20%
25. HIV 18%
26. Placebos 18%
27. Randomized Controlled Trials 18%
28. Retrospective Studies 18%
29. Diploidy 14%
30. Safety 13%
31. Senegal 10%
32. Cell Culture Techniques 10%
33. Income 8%
34. Mentha 8%
35. Viral Encephalitis 7%
36. Incidence 7%
37. Tropical Medicine 6%
38. Microscopy 6%
39. Injection Site Reaction 6%
40. Mass Drug Administration 5%
41. Schistosoma haematobium 5%
42. Chiroptera 5%
43. Schistosoma 5%